Literature DB >> 15373971

Ligand-dependent Toll-like receptor 4 (TLR4)-oligomerization is directly linked with TLR4-signaling.

Shin-ichiroh Saitoh1, Sachiko Akashi, Takenao Yamada, Natsuko Tanimura, Fumi Matsumoto, Koichi Fukase, Shoichi Kusumoto, Atsushi Kosugi, Kensuke Miyake.   

Abstract

Toll-like receptor 4 (TLR4) and MD-2 recognize lipid A, the active moiety of microbial lipopolysaccharide (LPS). Little is known about mechanisms for LPS recognition by TLR4/MD-2. We here showed, by using in vitro transfectants, ligand-induced TLR4-oligomerization, which required both membrane CD14 and MD-2. We previously reported that lipid IVa, a lipid A precursor, is agonistic on mouse TLR4/MD-2 but antagonistic on human TLR4/MD-2 and chimeric mouse TLR4/human MD-2. Lipid IVa triggered oligomerization of mouse TLR4/MD-2 but not human TLR4/MD-2 or chimeric mouse TLR4/human MD-2. Further, lipid IVa inhibited lipid A-dependent oligomerization of chimeric mouse TLR4/human MD-2. These results demonstrate that ligand-induced TLR4-oligomerization is directly linked with TLR4-signaling and suggest that MD-2 has an important role in regulating TLR4-oligomerization.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15373971     DOI: 10.1179/096805104225005904

Source DB:  PubMed          Journal:  J Endotoxin Res        ISSN: 0968-0519


  15 in total

1.  Visualization of BRI1 and BAK1(SERK3) membrane receptor heterooligomers during brassinosteroid signaling.

Authors:  Christoph A Bücherl; G Wilma van Esse; Alex Kruis; Jeroen Luchtenberg; Adrie H Westphal; José Aker; Arie van Hoek; Catherine Albrecht; Jan Willem Borst; Sacco C de Vries
Journal:  Plant Physiol       Date:  2013-06-24       Impact factor: 8.340

2.  Tracing the evolution of novel features of human Toll-like receptor 4.

Authors:  Jeremy A Anderson; Andrea N Loes; Grace L Waddell; Michael J Harms
Journal:  Protein Sci       Date:  2019-06-03       Impact factor: 6.725

3.  Characterization of TRIF selectivity in the AGP class of lipid A mimetics: role of secondary lipid chains.

Authors:  Juhienah K Khalaf; William S Bowen; Hélène G Bazin; Kendal T Ryter; Mark T Livesay; Jon R Ward; Jay T Evans; David A Johnson
Journal:  Bioorg Med Chem Lett       Date:  2014-12-17       Impact factor: 2.823

4.  Novel roles of lysines 122, 125, and 58 in functional differences between human and murine MD-2.

Authors:  Jozica Vasl; Alja Oblak; Theresa L Gioannini; Jerrold P Weiss; Roman Jerala
Journal:  J Immunol       Date:  2009-09-25       Impact factor: 5.422

Review 5.  Purified monomeric ligand.MD-2 complexes reveal molecular and structural requirements for activation and antagonism of TLR4 by Gram-negative bacterial endotoxins.

Authors:  Theresa L Gioannini; Athmane Teghanemt; DeSheng Zhang; Gregory Esparza; Liping Yu; Jerrold Weiss
Journal:  Immunol Res       Date:  2014-08       Impact factor: 2.829

6.  Mechanisms of Toll-like Receptor 4 Endocytosis Reveal a Common Immune-Evasion Strategy Used by Pathogenic and Commensal Bacteria.

Authors:  Yunhao Tan; Ivan Zanoni; Thomas W Cullen; Andrew L Goodman; Jonathan C Kagan
Journal:  Immunity       Date:  2015-11-03       Impact factor: 31.745

7.  Toll9 from Bombyx mori functions as a pattern recognition receptor that shares features with Toll-like receptor 4 from mammals.

Authors:  Ruonan Zhang; Xiaofeng Li; Jie Zhang; Yanjun Li; Yuan Wang; Yuhang Song; Feifei Ren; Huiyu Yi; Xiaojuan Deng; Yangjin Zhong; Yang Cao; Michael R Strand; Xiao-Qiang Yu; Wanying Yang
Journal:  Proc Natl Acad Sci U S A       Date:  2021-05-11       Impact factor: 11.205

Review 8.  Toll-like receptor and its roles in myocardial ischemic/reperfusion injury.

Authors:  Yu Fang; Jianguo Hu
Journal:  Med Sci Monit       Date:  2011-04

9.  LPS ligand and culture additives improve production of monomeric MD-1 and 2 in Pichia pastoris by decreasing aggregation and intermolecular disulfide bonding.

Authors:  Kristen E Mengwasser; Clare E Bryant; Nick J Gay; Monique Gangloff
Journal:  Protein Expr Purif       Date:  2010-12-02       Impact factor: 1.650

Review 10.  Immunopharmacology of lipid A mimetics.

Authors:  William S Bowen; Siva K Gandhapudi; Joseph P Kolb; Thomas C Mitchell
Journal:  Adv Pharmacol       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.